| 摘要 |
<p>In one or more embodiments, provided is a medicinal composition for FGF4 (fibroblast growth factor 4) gene-amplified tumor. In one embodiment, the present invention relates to a medicinal composition for improving FGF4 gene-amplified tumor, inhibiting the progression of the same, and/or treating the same, said medicinal composition comprising as an active ingredient at least one member selected from the group consisting of anti-FGF4 antibody, FGF receptor inhibitor, FGF4 siRNA, and FGF4 shRNA.</p> |
